Angus C. Russell Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Angus C. Russell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Angus C. Russell. Angus C. Russell is Director in TherapeuticsMD, Inc. ($COFF) and Director in BIOTIME INC ($BTX) and Director in Revance Therapeutics, Inc. ($RVNC) and Director in Mallinckrodt plc ($MNK).
Latest Insider Trading Transactions of Angus C. Russell
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BTX, MNK, RVNC, TXMD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 4,013 | 0 | 20,513 | 16.5 K to 20.5 K (+24.32 %) |
| Nov 16 2020 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Sell | S | 0.13 | 51,789 | 6,665 | 0 | 51.8 K to 0 (-100.00 %) |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Russell Angus C. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| May 15 2020 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 19.40 | 12,000 | 232,800 | 12,000 | |
| May 15 2020 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 6,000 | 0 | 16,500 | 10.5 K to 16.5 K (+57.14 %) |
| May 15 2020 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 2.96 | 12,042 | 35,644 | 51,789 | 63.8 K to 51.8 K (-18.87 %) |
| May 15 2020 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 2.96 | 12,042 | 35,644 | 51,789 | 63.8 K to 51.8 K (-18.87 %) |
| Aug 26 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.77 | 10,000 | 27,700 | 93,500 | 83.5 K to 93.5 K (+11.98 %) |
| Aug 15 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.99 | 10,000 | 29,900 | 83,500 | 73.5 K to 83.5 K (+13.61 %) |
| Aug 15 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.76 | 25,000 | 69,000 | 73,500 | 48.5 K to 73.5 K (+51.55 %) |
| Jul 03 2019 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| May 17 2019 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 26,759 | 0 | 63,831 | 37.1 K to 63.8 K (+72.18 %) |
| May 17 2019 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 15.21 | 11,764 | 178,930 | 37,072 | 48.8 K to 37.1 K (-24.09 %) |
| May 10 2019 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 12.82 | 9,000 | 115,380 | 9,000 | |
| May 10 2019 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 12.82 | 9,000 | 115,380 | 9,000 | |
| May 10 2019 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 4,500 | 0 | 10,500 | 6 K to 10.5 K (+75.00 %) |
| May 10 2019 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 4,500 | 0 | 10,500 | 6 K to 10.5 K (+75.00 %) |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| May 18 2018 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 26,141 | 0 | 48,836 | 22.7 K to 48.8 K (+115.18 %) |
| May 11 2018 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 29.15 | 6,000 | 174,900 | 6,000 | |
| May 11 2018 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 3,000 | 0 | 6,000 | 3 K to 6 K (+100.00 %) |
| Mar 05 2018 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 15.68 | 2,576 | 40,392 | 22,695 | 25.3 K to 22.7 K (-10.19 %) |
| Oct 03 2017 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 37.37 | 476 | 17,788 | 25,271 | 25.7 K to 25.3 K (-1.85 %) |
| Jul 05 2017 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| May 12 2017 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 20.90 | 6,000 | 125,400 | 6,000 | |
| May 12 2017 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Mar 03 2017 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 51.55 | 2,286 | 117,843 | 25,747 | 28 K to 25.7 K (-8.15 %) |
| Mar 03 2017 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 5,723 | 0 | 28,033 | 22.3 K to 28 K (+25.65 %) |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Oct 04 2016 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 1,057 | 0 | 22,310 | 21.3 K to 22.3 K (+4.97 %) |
| Jul 25 2016 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 1,037 | 0 | 21,253 | 20.2 K to 21.3 K (+5.13 %) |
| Jul 05 2016 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 2.72 | 20,000 | 54,400 | 20,000 | |
| May 09 2016 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 16.63 | 8,000 | 133,040 | 8,000 | |
| Mar 18 2016 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 55.69 | 458 | 25,506 | 20,216 | 20.7 K to 20.2 K (-2.22 %) |
| Mar 18 2016 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 4,041 | 0 | 20,674 | 16.6 K to 20.7 K (+24.30 %) |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Nov 10 2015 | BTX | BIOTIME INC | Russell Angus C. | Director | Buy | P | 3.83 | 50,000 | 191,500 | 67,500 | 17.5 K to 67.5 K (+285.71 %) |
| Aug 27 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 5.98 | 13,500 | 80,784 | 48,500 | 35 K to 48.5 K (+38.57 %) |
| Jul 06 2015 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 3.57 | 20,000 | 71,400 | 20,000 | |
| May 14 2015 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 20.42 | 8,000 | 163,360 | 8,000 | |
| May 13 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 6.15 | 35,000 | 215,317 | 35,000 | 0 to 35 K |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 23 2015 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Option Exercise | A | 0.00 | 1,893 | 0 | 0 | |
| Mar 23 2015 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Payment of Exercise | F | 131.21 | 606 | 79,513 | 16,633 | 17.2 K to 16.6 K (-3.52 %) |
| Mar 23 2015 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 1,715 | 0 | 17,239 | 15.5 K to 17.2 K (+11.05 %) |
| Mar 23 2015 | MNK | Mallinckrodt plc | Russell Angus C. | Director | Grant | A | 0.00 | 1,893 | 0 | 15,524 | 13.6 K to 15.5 K (+13.89 %) |
Page: 1